1. Home
  2. ZUMZ vs LXEO Comparison

ZUMZ vs LXEO Comparison

Compare ZUMZ & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zumiez Inc.

ZUMZ

Zumiez Inc.

HOLD

Current Price

$13.68

Market Cap

304.2M

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$3.01

Market Cap

348.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZUMZ
LXEO
Founded
1978
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
304.2M
348.7M
IPO Year
2005
2023

Fundamental Metrics

Financial Performance
Metric
ZUMZ
LXEO
Price
$13.68
$3.01
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $20.30
AVG Volume (30 Days)
298.5K
★ 1.9M
Earning Date
12-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 966.67
39.81
EPS
N/A
★ N/A
Revenue
★ $929,057,000.00
$654,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.92
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 4.48
N/A
52 Week Low
$13.07
$2.55
52 Week High
$31.70
$10.99

Technical Indicators

Market Signals
Indicator
ZUMZ
LXEO
Relative Strength Index (RSI) 40.95 39.51
Support Level $13.07 $2.98
Resistance Level $14.86 $3.68
Average True Range (ATR) 0.59 0.23
MACD 0.13 0.02
Stochastic Oscillator 25.26 41.18

Price Performance

Historical Comparison
ZUMZ
LXEO

About ZUMZ Zumiez Inc.

Zumiez Inc is a United States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art, action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: